Sarah Ford | April 18, 2014
Researcher Examines Impact of Extra Chromosome on Acute Myeloid Leukemia
David Gordon, MD, PhD at Dana Farber Cancer Institute is a CureSearch Young Investigator examining the impact of trisomy 8 on acute myeloid leukemia (AML). Of the 500 children diagnosed with AML each year, between 10-20% of an extra chromosome 8, called trisomy 8.
Dr. Gordon suspects that trisomy 8 contributes to the creation of cancerous cells because certain genes are expressed when an abnormal number of chromosomes are present. Using three cell lines he previously developed, Dr. Gordon spent the first year of his CureSearch grant screening the cell lines for new AML target genes and investigating the impact of trisomy 8 in blood cell development.
In the coming year, Dr. Gordon will explore how these genes, and their interaction with trisomy 8, lead to the development of AML.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Nurturing Payroll Giving Donors: 5 Tips to Deepen Engagement
Payroll giving donors are some of the most consistent and committed supporters nonprofits have, but they’re often overlooked in day-to-day fundraising strategies. These donors contribute…
Read Article
How to Align Your Company’s Values with Your Hiring Process
Hiring is about more than filling roles—it’s about shaping the future of your company. Every new team member contributes to the culture you’re building, and…
Read Article
Minority Mental Health Awareness Month
July is Minority Mental Health Awareness Month, a time dedicated to raising awareness about the unique mental health challenges faced by minority communities. It’s an…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
